DRD2 and schizophrenia: Nevertheless, the co-administration of raclopride and idazoxan was not able to reverse PPI deficit in rat animal model of schizophrenia, challenging the hypothesis that simple α2/D2R blockade may elicit atypical antipsychotic activity [142].